Aspen’s CEO, Stephen Saad, says he is optimistic that the results for the second half of this financial year will not only exceed those reported for the first half but will also exceed those of the second half of the prior year.
Aspen will receive R523 million from the Bill & Melinda Gates Foundation and the Norway-headquartered Coalition for Epidemic Preparedness Innovations to support the manufacture of lifesaving routine and outbreak vaccines for Africa.
Aspen Pharmacare has wrapped up pacts to secure $30m (R526.4m) worth of funding from the Gates Foundation and the Coalition for Epidemic Preparedness Innovations to help make affordable vaccines for Africa, the company said on Monday.
Africa will now have access to Covid-19 and other vaccines thanks to a new vaccine plant in Senegal which has received €75m from the European Investment Bank.